Acorda Therapeutics
Adam Hartman is a Senior Research Engineer at Acorda Therapeutics, Inc. since June 2018, where responsibilities include scaling up commercial processes for pharmaceutical spray dryers and designing studies for experimental design generation. Previously, Adam served as a Research Engineer, optimizing mRNA powders for inhalation delivery and contributing to a pending patent. Other notable experience includes a Pharmaceutical Development Co-op at Concert Pharmaceuticals, Inc., where Adam developed crystallization pathways for active pharmaceutical ingredients, and an Electrochemical Co-op at Nuvera Fuel Cells, LLC, focused on system failures in fuel cells. Earlier roles include a Formulation Co-op at Selecta Biosciences, synthesizing vaccine nanoparticles, and tutoring at Northeastern University. Adam holds a Bachelor of Science in Chemical Engineering from Northeastern University and graduated from Ashland High School.
This person is not in the org chart
This person is not in any offices
Acorda Therapeutics
1 followers
Acorda Therapeutics is a publicly-traded (NASDAQ: ACOR) biotechnology company whose mission is to develop therapies that restore neurological function and improve the lives of people with neurological disorders.